参考文献/References:
[1]Umanath K,Lewis JB.Update on diabetic nephropathy: core curriculum 2018[J].AmJ Kidney Dis,2018,71(6):884-895.[2]Zheng C,Huang L,Luo W,et al.Inhibition of STAT3 in tubular epithelial cells prevents kidney fibrosis and nephropathy in STZ-induced diabetic mice[J].Cell Death Dis,2019,10(11):848.[3]Xiong YB,Zhou LL.The signaling of cellular senescence in diabetic nephropathy[J].Oxidative Med Cell Longev,2019,2019:7495629.[4]Sanajou D,Ghorbani Haghjo A,Argani H,et al.AGE-RAGE axis blockade in diabetic nephropathy: current status and future directions[J].Eur J Pharmacol,2018,833:158-164.[5]Kim Y,Park CW.New therapeutic agents in diabetic nephropathy[J].Korean J Intern Med,2017,32(1):11-25.[6]Meza Letelier CE,San Martín Ojeda CA,Ruiz Provoste JJ,et al.Pathophysiology of diabetic nephropathy: a literature review[J].Medwave,2017,17(1):e6839.[7]Rajabi M,Mohaddes G,Farajdokht F,et al.Impact of loganin on pro-inflammatory cytokines and depression- and anxiety-like behaviors in male diabetic rats[J].Physiol Int,2018,105(2):116-126.[8]Hong JN,Li WW,Wang LL,et al.Jiangtang Decoction ameliorate diabetic nephropathy through the regulation of PI3K/Akt-mediated NF-κB pathways in KK-Ay mice[J].Chin Med,2017,12:13.[9]Tziomalos K,Athyros VG.Diabetic nephropathy: new risk factors and improvements in diagnosis[J].Rev Diabet Stud,2015,12(1-2):110-118.[10]Keri KC,Samji NS,Blumenthal S.Diabetic nephropathy: newer therapeutic perspectives[J].J Community Hosp Intern Med Perspect,2018,8(4):200-207.[11]Rayego-Mateos S,Morgado-Pascual JL,Opazo-Ríos L,et al.Pathogenic pathways and therapeutic approaches targeting inflammation in diabetic nephropathy[J].Int J Mol Sci,2020,21(11):E3798.[12]Maher NA,Yasser EM,Ashry GO,et al.Diabetic nephropathy following posttransplant diabetes mellitus[J].Exp Clin Transplant Off J Middle East Soc Organ Transplant,2019,17(2):138-146.[13]Papadopoulou-Marketou N,Kanaka-Gantenbein C,Marketos N,et al.Biomarkers of diabetic nephropathy: a 2017 update[J].Crit Rev Clin Lab Sci,2017,54(5):326-342.[14]Araújo LS,Torquato BGS,daSilva CA,et al.Renal expression of cytokines and chemokines in diabetic nephropathy[J].BMC Nephrol,2020,21(1):308.[15]Niewczas MA,Pavkov ME,Skupien J,et al.A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes[J].Nat Med,2019,25(5):805-813.[16]Flyvbjerg A.The role of the complement system in diabetic nephropathy[J].Nat Rev Nephrol,2017,13(5):311-318.[17]Cui WP,Min X,Xu XH,et al.ole of nuclear factor erythroid 2-related factor 2 in diabetic nephropathy[J].J Diabetes Res,2017,2017:3797802.[18]Alicic RZ,Rooney MT,Tuttle KR.Diabetic kidney disease: challenges, progress, and possibilities[J].Clin J Am Soc Nephrol,2017,12(12):2032-2045.[19]Malek V,Sharma N,Sankrityayan H,et al.Concurrent neprilysin inhibition and renin-angiotensin system modulations prevented diabetic nephropathy[J].Life Sci,2019,221:159-167.[20]Matoba K,Takeda Y,Nagai Y,et al.Unraveling the role of inflammation in the pathogenesis of diabetic kidney disease[J].Int J Mol Sci,2019,20(14):E3393.[21]Toth-Manikowski S,Atta MG.Diabetic kidney disease: pathophysiology and therapeutic targets[J].J Diabetes Res,2015,2015:697010.[22]Brosius FC,Tuttle KR,Kretzler M.JAK inhibition in the treatment of diabetic kidney disease[J].Diabetologia,2016,59(8):1624-1627.[23]Tuttle KR,Brosius FC,Adler SG,et al.JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial[J].Nephrol Dial Transplant,2018,33(11):1950-1959.[24]Tung CW,Hsu YC,Shih YH,et al.Glomerular mesangial cell and podocyte injuries in diabetic nephropathy[J].Nephrology (Carlton),2018,23(Suppl 4):32-37.[25]Tesch GH.Diabetic nephropathy - is this an immune disorder?[J].ClinSci(Lond),2017,131(16):2183-2199.[26]Calle P,Hotter G.Macrophage phenotype and fibrosis in diabetic nephropathy[J].Int J Mol Sci,2020,21(8):E2806.[27]Nishiyama A,Kobori H.Independent regulation of renin-angiotensin-aldosterone system in the kidney[J].Clin Exp Nephrol,2018,22(6):1231-1239.[28]Magee C,Grieve DJ,Watson CJ,et al.Diabetic nephropathy: a tangled web to unweave[J].Cardiovasc Drugs Ther,2017,31(5-6):579-592.[29]Lee JY,Yang JW,Han BG,et al.Adiponectin for the treatment of diabetic nephropathy[J].Korean J Intern Med,2019,34(3):480-491.[30]Kawanami D,Matoba K,Utsunomiya K.Dyslipidemia in diabetic nephropathy[J].Ren Replace Ther,2016,2(1):16.[31]Podgórski P,Konieczny A,Lis L,et al.Glomerular podocytes in diabetic renal disease[J].Adv Clin Exp Med,2019,28(12):1711-1715.[32]Opazo-Ríos L,Mas S,Marín-Royo G,et al.Lipotoxicity and diabetic nephropathy: novel mechanistic insights and therapeutic opportunities[J].Int J Mol Sci,2020,21(7):E2632.[33]Nadolnik K,Skrypnik D,Skrypnik K,et al.Diabetic nephropathy in the elderly - clinical practice[J].Rocz Panstw Zakl Hig,2018,69(4):327-334.[34]Geng XD,Wang WW,Feng Z,et al.Identification of key genes and pathways in diabetic nephropathy by bioinformatics analysis[J].J Diabetes Investig,2019,10(4):972-984.[35]Arora MK,Sarup Y,Tomar R,et al.Amelioration of diabetes-induced diabetic nephropathy by aloe vera: implication of oxidative stress and hyperlipidemia[J].J Diet Suppl,2019,16(2):227-244.[36]Liu WJ,Huang WF,Ye L,et al.The activity and role of autophagy in the pathogenesis of diabetic nephropathy[J].Eur Rev Med Pharmacol Sci,2018,22(10):3182-3189.[37]Thongnak L,Pongchaidecha A,Lungkaphin A.Renal lipid metabolism and lipotoxicity in diabetes[J].Am J Med Sci,2020,359(2):84-99.[38]Patel DM,Bose M,Cooper ME.Glucose and blood pressure-dependent pathways-the progression of diabetic kidney disease[J].IntJ Mol Sci,2020,21(6):2218.[39]Lindblom R,Higgins G,Coughlan M,et al.Targeting mitochondria and reactive oxygen species-driven pathogenesis in diabetic nephropathy[J].Rev Diabet Stud,2015,12(1-2):134-156.[40]Horikoshi S,Fukuda N,Tsunemi A,et al.Contribution of TGF-β1 and effects of gene silencer pyrrole-imidazole polyamides targeting TGF-β1 in diabetic nephropathy[J].Molecules,2020,25(4):E950.[41]Penno G,Garofolo M,Del Prato S.Dipeptidyl peptidase-4 inhibition in chronic kidney disease and potential for protection against diabetes-related renal injury[J].Nutr Metab Cardiovasc Dis,2016,26(5):361-373.[42]Kim MK.Treatment of diabetic kidney disease: current and future targets[J].Korean J Intern Med,2017,32(4):622-630.[43]Panchapakesan U,Pollock C.The role of dipeptidyl peptidase - 4 inhibitors in diabetic kidney disease[J].Front Immunol,2015,6:443.[44]Blázquez-Medela AM,López-Novoa JM,Martínez-Salgado C.Mechanisms involved in the genesis of diabetic nephropathy[J].Curr Diabetes Rev,2010,6(2):68-87.[45]Madhura B,Sadia A,Sharma P.Wnt signaling and podocyte dysfunction in diabetic nephropathy[J].J Investig Med Off Publ Am Fed Clin Res,2017,65(8):1093-1101.
相似文献/References:
[1]张西园.糖尿病与结直肠癌患者预后相关研究进展[J].医学信息,2018,31(01):55.[doi:10.3969/j.issn.1006-1959.2018.01.020]
ZHANG Xi-yuan.Research Progress in the Relationship between Diabetes and the Prognosis of Colorectal
Cancer[J].Journal of Medical Information,2018,31(17):55.[doi:10.3969/j.issn.1006-1959.2018.01.020]
[2]耿金萍.综合护理对甲状腺良性肿瘤并糖尿病患者手术效果的影响分析[J].医学信息,2018,31(01):163.[doi:10.3969/j.issn.1006-1959.2018.01.064]
GENG Jin-ping.Analysis of the Effect of Comprehensive Nursing on the Surgical Effect of Thyroid Benign
Tumor and Diabetic Patients[J].Journal of Medical Information,2018,31(17):163.[doi:10.3969/j.issn.1006-1959.2018.01.064]
[3]李雯婷,谈世华,余江明,等.踝肱指数检测在住院糖尿病患者中的重复性研究[J].医学信息,2018,31(03):159.[doi:10.3969/j.issn.1006-1959.2018.03.058]
LI Wen-ting,TAN Shi-hua,YU Jiang-ming,et al.Study on Reproducibility of Ankle-brachial Index in Inpatients with Diabetes Mellitus[J].Journal of Medical Information,2018,31(17):159.[doi:10.3969/j.issn.1006-1959.2018.03.058]
[4]刘 静.冠状动脉粥样硬化性心脏病合并糖尿病的血脂检验结果分析[J].医学信息,2018,31(04):154.[doi:10.3969/j.issn.1006-1959.2018.04.057]
LIU Jing.Analysis of Blood Lipid Test Results in Coronary Atherosclerotic Heart Disease Complicated with Diabetes Mellitus[J].Journal of Medical Information,2018,31(17):154.[doi:10.3969/j.issn.1006-1959.2018.04.057]
[5]谢勇丽,苏晓清,张雅薇.糖尿病痛性周围神经病变患者情绪调查分析[J].医学信息,2018,31(05):14.[doi:10.3969/j.issn.1006-1959.2018.05.005]
XIE Yong-li,SU Xiao-qing,ZHANG Ya-wei.Investigation and Analysis of Mood in Patients with Diabetic Peripheral Neuropathy[J].Journal of Medical Information,2018,31(17):14.[doi:10.3969/j.issn.1006-1959.2018.05.005]
[6]陈淑雯.肾衰宁联合科素亚治疗早期糖尿病肾病的临床观察[J].医学信息,2018,31(05):20.[doi:10.3969/j.issn.1006-1959.2018.05.007]
CHEN Shu-wen.Clinical Observation on Early Diabetic Nephropathy Treated by Shenshuaining Combined with Kosu[J].Journal of Medical Information,2018,31(17):20.[doi:10.3969/j.issn.1006-1959.2018.05.007]
[7]张雅薇,朱明慧.首发为动眼神经麻痹的糖尿病合并动眼神经麻痹误诊为痛性眼肌麻痹1例分析[J].医学信息,2018,31(05):23.[doi:10.3969/j.issn.1006-1959.2018.05.008]
ZHANG Ya-wei,ZHU Ming-hui.An Analysis of a Case of Diabetes Mellitus with Oculomotor Nerve Palsy Misdiagnosed as Painful Ophthalmoplegia[J].Journal of Medical Information,2018,31(17):23.[doi:10.3969/j.issn.1006-1959.2018.05.008]
[8]张宇宁.黄酮类化合物治疗糖尿病及其并发症的研究[J].医学信息,2018,31(05):50.[doi:10.3969/j.issn.1006-1959.2018.05.018]
ZHANG Yu-ning.Study on Flavonoids in the Treatment of Diabetes Mellitus and its Complications[J].Journal of Medical Information,2018,31(17):50.[doi:10.3969/j.issn.1006-1959.2018.05.018]
[9]柳 梅.头孢哌酮钠舒巴坦钠治疗糖尿病并发尿路感染的
临床效果观察[J].医学信息,2018,31(07):139.[doi:10.3969/j.issn.1006-1959.2018.07.047]
LIU Mei.Clinical Efficacy of Cefoperazone Sodium and Sulbactam Sodium in Treatment of Diabetes Complicated with Urinary Tract Infection[J].Journal of Medical Information,2018,31(17):139.[doi:10.3969/j.issn.1006-1959.2018.07.047]
[10]吕桂英.影响糖尿病患者药物治疗依从性相关因素临床分析[J].医学信息,2018,31(08):109.[doi:10.3969/j.issn.1006-1959.2018.08.036]
LV Gui-ying.Clinical Analysis of Factors Related to Compliance with Drug Therapy in Patients with Diabetes Mellitus[J].Journal of Medical Information,2018,31(17):109.[doi:10.3969/j.issn.1006-1959.2018.08.036]
[11]吴怡琪,卢 文.皮肤AGEs荧光检测对糖尿病肾病的临床意义[J].医学信息,2019,32(06):101.[doi:10.3969/j.issn.1006-1959.2019.06.031]
WU Yi-qi,LU Wen.Clinical Significance of Skin AGEs Fluorescence Detection in Diabetic Kidney Disease[J].Journal of Medical Information,2019,32(17):101.[doi:10.3969/j.issn.1006-1959.2019.06.031]
[12]王 静,郭宏敏.肝型脂肪酸结合蛋白在糖尿病中的研究[J].医学信息,2019,32(18):18.[doi:10.3969/j.issn.1006-1959.2019.18.007]
WANG Jing,GUO Hong-min.Study on Hepatic Fatty Acid Binding Protein in Diabetes[J].Journal of Medical Information,2019,32(17):18.[doi:10.3969/j.issn.1006-1959.2019.18.007]